Eli Lilly launched “TuneLab,” an AI/ML platform that gives selected biotechs access to drug-discovery models trained on years of Lilly research data. Initial public partners include Circle Pharma and insitro. Lilly says the first release reflects more than $1B worth of internal data investment. Lilly says biotechs run its models locally on their own infrastructure…
From data to drug candidates: Optimizing informatics for ML and GenAI
Machine learning (ML) has become a cornerstone of modern drug discovery. Today, many companies are taking ML developments a step further using generative AI (GenAI) to search for molecules under specific constraints, such as solubility and patent status, and to optimize for desired properties like potential therapeutic success. In doing so, GenAI can enhance the efficiency, speed…